John B Hynes Veterans Memorial Convention Center, Boston, MA
This is annual forum that focuses on novel predictive methods and technologies for the rational development and production of next-generation biological drug products. This 2013 program embraces regulatory aspects of such issues as aggregation and immunogenicity to utilizing biosimilars in therapeutic and biologic development.
IBC's Flexible Facilities conference is designed to bring together thought leaders from biologics drug developers, engineering firms, CMOs, technology providers and governmental bodies to share best practices and new ideas.